Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding How CDH1 Germline Mutations Affect Hereditary Lobular Breast Cancer

NCT04206891 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT04206891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04206891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding How CDH1 Germline Mutations Affect Hereditary Lobular Breast Cancer
Lead sponsor
European Institute of Oncology
Phase
Observational
Overall status
Completed
Start date
December 1, 2018
Completion date
November 26, 2025
Enrollment
421 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cdh1 gene inactivation, lobular breast carcinoma